Navigation Links
BD Receives FDA Approval for New Automated Cervical Cancer Screening System
Date:3/7/2016

FRANKLIN LAKES, N.J., March 7, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for its  BD Totalys™ MultiProcessor and BD Totalys™ SlidePrep instruments.

Together with the BD FocalPoint™ SlideProfiler, these innovations comprise the full BD Totalys System, which further automates slide preparation, imaging and review for use in cervical cancer screening, as well as providing ancillary testing aliquot capability. Increasing automation in the laboratory helps to reduce the potential for human error and increases lab workflow efficiency. The BD™ DataLink middleware connects the BD Totalys instruments to a Laboratory Information System, improving laboratory efficiency while providing continuous sample tracking to ensure patients get the right results.

The BD Totalys System combined with the BD SurePath™ liquid-based Pap test offers an improved automated process for cervical cancer screening laboratories versus current methods.

"We are very pleased to introduce the BD Totalys System in the United States," said Doug White, vice president and general manager, Women's Health & Molecular Diagnostics. "The BD Totalys System provides clinical laboratories with a highly customizable, automated liquid-based cytology solution to help improve laboratory efficiency, enhance sample tracking and maintain high quality diagnostic results."

The BD Totalys System provides a balance of automation and flexibility to help meet the needs of medium and high throughput cervical cancer screening labs by increasing workflow efficiency, reducing technician hands-on time and repetitive motion and improving usability, user safety, overall process quality and functionality.

About BD
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance cellular studies and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit www.bd.com.

Contact:

Matthew Coppola
BD Public Relations
201.847.7330
Matthew_R_Coppola@bd.com

Monique N. Dolecki
BD Investor Relations
201.847.5378
Monique_Dolecki@bd.com


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Corvia Medical Receives IDE Approval For REDUCE LAP-HF I Clinical Study & Announces Agreement With Strategic Partner For Exclusive Option To Purchase Company
2. Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures
3. Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis
4. AbbVie Receives EMA Orphan Drug Designation for Investigational Compound Venetoclax for the Treatment of Acute Myeloid Leukemia (AML)
5. MediHerb/Integria Healthcare Receives ABCs Varro E. Tyler Award for Phytomedicinal Research
6. Renova Therapeutics receives additional NIH grant to continue paracrine gene therapy research for congestive heart failure
7. Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia
8. Luminex Corporation Receives Medical Device License for ARIES System and ARIES HSV 1&2 Assay in Canada
9. Bracco Diagnostics Inc. Receives Second U.S. FDA Approval for Barium-Based Products, The First in Computed Tomography
10. BiondVax Receives Additional Grant Approval
11. ivWatch, LLC Receives 2016 Virginia Governors Outstanding STEM Award for Science Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2019)... ... ... TopConsumerReviews.com recently gave its best-in-class 5 star rating to Lice Clinics of ... are surprisingly common, especially in schools and other environments where people come in close ... of uncleanliness; in fact, lice prefer to live on clean hair! Getting rid of ...
(Date:2/19/2019)... (PRWEB) , ... February 19, ... ... MSMOT, has joined Coker Group as Senior Vice President. Kunney, based in ... teams and achieve cross-functional business objectives that effectively integrate within the clinical ...
(Date:2/19/2019)... ... February 19, 2019 , ... Sports are putting an increasing ... That is according to a 2018 article in the British Journal of Sports Medicine ... orthopaedic surgeon Kevin D. Plancher, MD, MPH. , This upward trend in ...
Breaking Medicine Technology:
(Date:2/19/2019)... WORCESTER, Mass. (PRWEB) , ... February 19, 2019 ... ... on the impact of weight stigma in pregnant and postpartum women, a team ... stigma during pregnancy and early postpartum often show increased depressive symptoms, greater weight ...
(Date:2/19/2019)... , ... February 19, 2019 , ... Landscape Structures Inc., ... new spinners that are sure to be a stunning and fun addition to any ... and the new Chill™ and Curva™ Spinners will provide kids’ brains with valuable equilibrium ...
(Date:2/19/2019)... , ... February 19, 2019 , ... ... of medical experience to The Oncology Institute of Hope and Innovation. , Dr. ... graduated magna cum laude. He received his medical degree from the University of ...
(Date:2/19/2019)... ... February 19, 2019 , ... ClearHealth Quality Institute (CHQI) has ... LLP, as Recognized Consultants. The CHQI Recognized Consultant Program trains third-parties to assist ... , Ms. Wein and Mr. Einhorn are part of Foley’s Telemedicine & ...
(Date:2/19/2019)... ... February 18, 2019 , ... AdventHealth Connerton is the first ... Sanitizing Stations to maximize infection control for patients and their families. The patented, ... and C. difficile, which can be transmitted from the bottoms of shoes to ...
Breaking Medicine News(10 mins):